NL8900742A - Farmaceutische preparaten met een werking in het bijzonder op het hart en het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan. - Google Patents

Farmaceutische preparaten met een werking in het bijzonder op het hart en het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan. Download PDF

Info

Publication number
NL8900742A
NL8900742A NL8900742A NL8900742A NL8900742A NL 8900742 A NL8900742 A NL 8900742A NL 8900742 A NL8900742 A NL 8900742A NL 8900742 A NL8900742 A NL 8900742A NL 8900742 A NL8900742 A NL 8900742A
Authority
NL
Netherlands
Prior art keywords
selenium
fatty acids
weight
preparation
unsaturated fatty
Prior art date
Application number
NL8900742A
Other languages
English (en)
Dutch (nl)
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of NL8900742A publication Critical patent/NL8900742A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
NL8900742A 1988-03-23 1989-03-23 Farmaceutische preparaten met een werking in het bijzonder op het hart en het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan. NL8900742A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart
HU148488 1988-03-23

Publications (1)

Publication Number Publication Date
NL8900742A true NL8900742A (nl) 1989-10-16

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900742A NL8900742A (nl) 1988-03-23 1989-03-23 Farmaceutische preparaten met een werking in het bijzonder op het hart en het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan.

Country Status (15)

Country Link
JP (1) JPH0222228A (ja)
KR (1) KR890014104A (ja)
BE (1) BE1003021A3 (ja)
CA (1) CA1319607C (ja)
CH (1) CH677732A5 (ja)
DE (1) DE3909707A1 (ja)
ES (1) ES2014060A6 (ja)
FI (1) FI891438A (ja)
FR (1) FR2628972B1 (ja)
GB (1) GB2216421A (ja)
HU (1) HU210122B (ja)
IT (1) IT1229205B (ja)
LU (1) LU87488A1 (ja)
NL (1) NL8900742A (ja)
SE (1) SE8901041L (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
BR0309740A (pt) * 2002-05-03 2005-02-22 Pronova Biocare As Uso de ácido eicosapentaenóico (epa), ácido docosaexaenóico (dha) ou de uma mistura de epa e dha ou de um sal ou derivado farmaceuticamente aceitáveis dos mesmos
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
EP1776159A1 (en) * 2004-08-09 2007-04-25 Enzymotec Ltd. Food products for diabetics
JP5118965B2 (ja) 2004-08-10 2013-01-16 エンジモテック リミテッド 植物成分を必要とする治療方法
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
IT1229205B (it) 1991-07-25
FI891438A0 (fi) 1989-03-23
DE3909707A1 (de) 1989-10-05
HU210122B (en) 1995-02-28
FR2628972B1 (fr) 1994-09-23
FR2628972A1 (fr) 1989-09-29
BE1003021A3 (fr) 1991-10-29
GB2216421A (en) 1989-10-11
SE8901041L (sv) 1989-09-24
IT8919876A0 (it) 1989-03-23
HUT60436A (en) 1992-09-28
CH677732A5 (ja) 1991-06-28
KR890014104A (ko) 1989-10-21
FI891438A (fi) 1989-09-24
SE8901041D0 (sv) 1989-03-23
CA1319607C (en) 1993-06-29
ES2014060A6 (es) 1990-06-16
GB8906856D0 (en) 1989-05-10
LU87488A1 (fr) 1990-10-02
JPH0222228A (ja) 1990-01-25

Similar Documents

Publication Publication Date Title
NL8900742A (nl) Farmaceutische preparaten met een werking in het bijzonder op het hart en het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan.
AU660360B2 (en) Antioxidant system for powdered nutritional products
KR101451415B1 (ko) 불비누화 물질 함량을 저감시킨 미생물 유지의 제조 방법 및 그 유지
KR20030033010A (ko) 조 피유에프에이 오일의 정제방법
MXPA04012915A (es) Preparacion de aceite microbiano.
WO1994028891A1 (en) Method of treating coronary vascular disease using docosahexaenoic acid
CN107456539A (zh) 用于减少主要心脏事件发生的包括红曲米提取物和ω‑3多不饱和脂肪酸或其衍生物的物质
KR101204969B1 (ko) 신규한 세포 보존 기술을 이용한 폴리불포화 지방산의 생산방법
NL8800693A (nl) Farmaceutische preparaten met een werking op het hart en op het cardiovasculaire systeem, alsmede werkwijze voor de bereiding ervan.
TW200522939A (en) Composition having action preventing or alleviating symptoms or diseases due to aging of blood vessels
IE58891B1 (en) Pharmaceutical and dietary compositions containing linolenic acids for the treatment of benign prostatic hypertrophy
NL8800691A (nl) Dieetpreparaat en werkwijze voor de bereiding ervan.
JPH0127A (ja) 心臓および心臓血管系に作用する薬剤並びにその製造方法
JP2677949B2 (ja) アラキドン酸含有健康食品
NL8800690A (nl) Huid-regenererend kosmetisch preparaat en werkwijze voor de bereiding ervan.
JPS6131092A (ja) エイコサペンタエン酸の酵素的生産方法
CA2123587A1 (fr) Produit bactericide, composition pharmaceutique le contenant et additif alimentaire
Berry et al. Precursor Therapy with Orthomolecular Nutrition
JP3005261B2 (ja) グルタチオンペルオキシダーゼの製造法およびその用途
JP2002335951A (ja) 脂質含有酵母の製造方法
JPH078222A (ja) ドコサヘキサエン酸カルシウム塩含有健康食品およびその製造方法
JP2005087194A (ja) 微生物を用いた共役高度不飽和脂肪酸含有培養物および共役高度不飽和脂肪酸含有油脂の製造方法

Legal Events

Date Code Title Description
BV The patent application has lapsed